Allogene Therapeutics is a biotechnology company in the healthcare sector on NASDAQ, led by Geoffrey Parker, with a market cap of $339.3M. As of Q3 2025, 73% of shares are held by 167 institutional investors, with PFIZER INC as the largest holder at 9.93%.
Overview of institutional ownership in ALLO as of Q3 2025 with a market cap of $275.1M
Based on market cap of $275.1M as of Q3 2025. Institutional (non-HF) excludes hedge funds to avoid double counting.
Institutions with the largest positions in ALLO as of Q3 2025
| Institution | Position Value |
|---|---|
PFIZER INC Institution | $27.3M 6.25% of portfolio |
T TPG GP A, LLC Institution | $23.2M 1.26% of portfolio |
B BlackRock, Inc. Institution | $21.7M 0.00% of portfolio |
CITADEL ADVISORS LLC Hedge Fund•Multi-Strategy | $17.3M 0.01% of portfolio |
VANGUARD GROUP INC Institution | $11.2M 0.00% of portfolio |
PRIMECAP MANAGEMENT CO/CA/ Long Only Manager | $8.8M 0.01% of portfolio |
Woodline Partners LP Hedge Fund•Long/Short | $5.4M 0.03% of portfolio |
Frazier Life Sciences Management, L.P. Venture Capital | $4.8M 0.14% of portfolio |
GEODE CAPITAL MANAGEMENT LLC ETF Provider | $4.8M 0.00% of portfolio |
PRICE T ROWE ASSOCIATES INC /MD/ Long Only Manager | $4.6M 0.00% of portfolio |
Institutional buying and selling activity for ALLO in Q3 2025
| Institution | Net Bought |
|---|---|
CITADEL ADVISORS LLC Hedge Fund•Multi-Strategy | +$4.6M +3.7M shares |
MILLENNIUM MANAGEMENT LLC Hedge Fund•Multi-Strategy | +$2.3M +1.9M shares |
AQR CAPITAL MANAGEMENT LLC Hedge Fund•Multi-Strategy | +$2.2M +1.8M shares |
TWO SIGMA INVESTMENTS LLC Hedge Fund•Multi-Strategy | +$2.2M +1.8M shares |
UBS Group AG Institution | +$1.9M +1.5M shares |
PRIMECAP MANAGEMENT CO/CA/ Long Only Manager | +$1.7M +1.4M shares |
RENAISSANCE TECHNOLOGIES LLC Hedge Fund•Quant | +$1.5M +1.2M shares |
TWO SIGMA ADVISERS, LLC Hedge Fund•Multi-Strategy | +$1.3M +1.0M shares |
J JANE STREET GROUP, LLC Institution | +$995.9K +803.1K shares |
VANGUARD GROUP INC Institution | +$944.4K +761.6K shares |
| Institution | Net Sold |
|---|---|
C Capital World Investors Institution | −$12.6M −11.2M shares |
D Darwin Global Management, Ltd. Institution | −$12.4M −10.5M shares |
GOLDMAN SACHS GROUP INC Institution | −$5.3M −4.3M shares |
Foresite Capital Management VI LLC Venture Capital | −$3.2M −2.9M shares |
GILEAD SCIENCES, INC. Institution | −$1.3M −1.2M shares |
DIMENSIONAL FUND ADVISORS LP Long Only Manager | −$800.7K −645.7K shares |
B BlackRock, Inc. Institution | −$474.6K −382.7K shares |
PRICE T ROWE ASSOCIATES INC /MD/ Long Only Manager | −$438.2K −353.4K shares |
Kingstone Capital Partners Texas, LLC RIA/Wealth | −$389.7K −344.9K shares |
GSA CAPITAL PARTNERS LLP Hedge Fund•Quant | −$383.5K −309.2K shares |
Institutions that initiated new positions or completely exited ALLO in Q3 2025
| Institution | Position Value |
|---|---|
A AustralianSuper Pty Ltd Institution | $473.9K 382.1K shares |
B BRIDGEWAY CAPITAL MANAGEMENT INC Long Only Manager | $310.0K 250.0K shares |
LEVIN CAPITAL STRATEGIES, L.P. Hedge Fund•Multi-Strategy | $65.1K 52.5K shares |
SRS Capital Advisors, Inc. RIA/Wealth | $46.4K 37.4K shares |
Mariner Wealth Advisors, LLC RIA/Wealth | $45.5K 36.7K shares |
Scientech Research LLC Hedge Fund•Market Neutral | $33.0K 26.6K shares |
Savant Capital, LLC RIA/Wealth | $26.8K 21.6K shares |
DLK Investment Management, LLC RIA/Wealth | $12.4K 10.0K shares |
Point72 Ltd RIA/Wealth | $7.7K 6.2K shares |
Point72 Europe LLP Digital Asset Manager | $1.3K 1.1K shares |
| Institution | Previous Position |
|---|---|
C Capital World Investors Institution | $12.6M 11.2M shares |
D Darwin Global Management, Ltd. Institution | $12.4M 10.5M shares |
Foresite Capital Management VI LLC Venture Capital | $3.2M 2.9M shares |
GILEAD SCIENCES, INC. Institution | $1.3M 1.2M shares |
Kingstone Capital Partners Texas, LLC RIA/Wealth | $389.7K 344.9K shares |
BOURGEON CAPITAL MANAGEMENT LLC RIA/Wealth | $124.3K 110.0K shares |
B Brevan Howard Capital Management LP Institution | $92.5K 81.8K shares |
S Skopos Labs, Inc. RIA/Wealth | $44.9K 30.7K shares |
$27.7K 24.5K shares | |
SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC Hedge Fund•Distressed | $17.0K 15.1K shares |
Institutions with the largest Call and Put options positions in ALLO as of Q3 2025
| Institution | Position Value |
|---|---|
SUSQUEHANNA INTERNATIONAL GROUP, LLP Private Equity | $59.5K 480.0 contracts |
CITADEL ADVISORS LLC Hedge Fund•Multi-Strategy | $33.0K 266.0 contracts |
R Raiffeisen Bank International AG Institution | $2.5K 20.0 contracts |
| Institution | Position Value |
|---|---|
CITADEL ADVISORS LLC Hedge Fund•Multi-Strategy | $25.5K 206.0 contracts |
SUSQUEHANNA INTERNATIONAL GROUP, LLP Private Equity | $19.3K 156.0 contracts |
Institutions with ALLO as the highest % of their portfolio as of Q3 2025
| Institution | Portfolio Weight |
|---|---|
V Vida Ventures Advisors, LLC Institution | 7.59% $2.2M |
PFIZER INC Institution | 6.25% $27.3M |
Wildcat Capital Management, LLC Private Equity | 2.50% $3.6M |
T TPG GP A, LLC Institution | 1.26% $23.2M |
Patient Square Capital LP Private Equity | 0.99% $3.7M |
D DAFNA Capital Management LLC Hedge Fund•Event Driven | 0.43% $1.7M |
Harold Davidson & Associates Inc. RIA/Wealth | 0.17% $366.3K |
Frazier Life Sciences Management, L.P. Venture Capital | 0.14% $4.8M |
L Lynx1 Capital Management LP Hedge Fund•Sector | 0.14% $677.2K |
M Moloney Securities Asset Management, LLC RIA/Wealth | 0.08% $637.4K |
Discover hedge funds investing in ALLO
| Top Holding | Sector | Market Value | Weight |
|---|---|---|---|
Biotechnology Healthcare | $144.4M | 29.40% | |
Biotechnology Healthcare | $109.9M | 22.37% | |
Biotechnology Healthcare | $104.3M | 21.23% |
We use cookies for analytics. See our Privacy and Cookie Policy.